TTD_Target_ID	Target_Name	TTD_Drug_ID	Drug_Name	Drug_Highest_Status	Drug_PubchemID	Molecular_Formula	Molecular_Weight	Canonical_SMILES	Activity	Binder_Type
T55398	Renal carcinoma antigen NY-REN-64	B94OFE	CID 73670172	Investigative	73670172	C21H25N5O3S	427.5	C1CC1CNC2=NC=C(C(=N2)N[C@@H]3C[C@@H]([C@H]([C@H]3O)O)CO)C4=NC5=CC=CC=C5S4	IC50 = 333000 nM	Non binder
T55398	Renal carcinoma antigen NY-REN-64	BJB48Q	Schembl21106727	Investigative	118729813	C21H25N5O3S	427.5	C1CC(C1)NC2=NC=C(C(=N2)N[C@@H]3C[C@@H]([C@H]([C@H]3O)O)CO)C4=NC5=CC=CC=C5S4	IC50 = 403000 nM	Non binder
T55398	Renal carcinoma antigen NY-REN-64	BM6ZU5	CID 73670344	Investigative	73670344	C22H27N5O4S	457.5	C1COCCC1NC2=NC=C(C(=N2)N[C@@H]3C[C@@H]([C@H]([C@H]3O)O)CO)C4=NC5=CC=CC=C5S4	IC50 = 1081000 nM	Non binder
T55398	Renal carcinoma antigen NY-REN-64	BT5AL7	CID 73670345	Investigative	73670345	C23H29N5O3S	455.6	C1CCC(CC1)NC2=NC=C(C(=N2)N[C@@H]3C[C@@H]([C@H]([C@H]3O)O)CO)C4=NC5=CC=CC=C5S4	IC50 = 3012000 nM	Non binder
T55398	Renal carcinoma antigen NY-REN-64	BU0WI5	CID 73670173	Investigative	73670173	C21H27N5O4S	445.5	COCCCNC1=NC=C(C(=N1)N[C@@H]2C[C@@H]([C@H]([C@H]2O)O)CO)C3=NC4=CC=CC=C4S3	IC50 = 228000 nM	Non binder
T55398	Renal carcinoma antigen NY-REN-64	BYAM53	(1r,2s,3r,5r)-3-{[5-(1,3-Benzothiazol-2-Yl)-2-(Propylamino)pyrimidin-4-Yl]amino}-5-(Hydroxymethyl)cyclopentane-1,2-Diol	Investigative	91844450	C20H25N5O3S	415.5	CCCNC1=NC=C(C(=N1)N[C@@H]2C[C@@H]([C@H]([C@H]2O)O)CO)C3=NC4=CC=CC=C4S3	IC50 = 1193000 nM	Non binder